SRC
MRK icon

Sage Rhino Capital’s Merck MRK Stock Holding History

Sage Rhino Capital’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25M Buy
10,414
+15
+0.1% +$1.73K 0.23% 84
2025
Q4 		$1.09M Sell
10,399
-155
-1% -$14.6K 0.21% 90
2025
Q3 		$886K Buy
10,554
+23
+0.2% +$1.89K 0.17% 104
2025
Q2 		$834K Sell
10,531
-50
-0.5% -$3.97K 0.18% 100
2025
Q1 		$950K Buy
10,581
+91
+0.9% +$8.5K 0.22% 85
2024
Q4 		$1.04M Sell
10,490
-57
-0.5% -$5.88K 0.23% 83
2024
Q3 		$1.2M Sell
10,547
-59
-0.6% -$7.01K 0.27% 73
2024
Q2 		$1.31M Sell
10,606
-2
-0% -$258 0.31% 68
2024
Q1 		$1.4M Buy
10,608
+201
+2% +$24.8K 0.33% 63
2023
Q4 		$1.13M Sell
10,407
-13
-0.1% -$1.35K 0.29% 69
2023
Q3 		$1.07M Buy
10,420
+31
+0.3% +$3.34K 0.3% 70
2023
Q2 		$1.2M Sell
10,389
-36
-0.3% -$4.09K 0.33% 66
2023
Q1 		$1.11M Sell
10,425
-123
-1% -$13.3K 0.32% 64
2022
Q4 		$1.17M Buy
10,548
+24
+0.2% +$2.45K 0.37% 56
2022
Q3 		$906K Sell
10,524
-75
-0.7% -$6.7K 0.36% 50
2022
Q2 		$966K Buy
10,599
+135
+1% +$12K 0.37% 47
2022
Q1 		$859K Buy
10,464
+48
+0.5% +$3.78K 0.26% 69
2021
Q4 		$798K Buy
10,416
+63
+0.6% +$5.02K 0.22% 84
2021
Q3 		$778K Buy
10,353
+63
+0.6% +$4.79K 0.24% 72
2021
Q2 		$800K Sell
10,290
-334
-3% -$24.8K 0.24% 74
2021
Q1 		$781K Sell
10,624
-8
-0.1% -$590 0.26% 70
2020
Q4 		$830K Buy
10,632
+70
+0.7% +$5.35K 0.33% 56
2020
Q3 		$836K Buy
10,562
+20
+0.2% +$1.57K 0.4% 49
2020
Q2 		$778K Sell
10,542
-15
-0.1% -$1.13K 0.41% 53
2020
Q1 		$775K Sell
10,557
-56
-0.5% -$4.4K 0.56% 39
2019
Q4 		$907K Buy
10,613
+51
+0.5% +$4.19K 0.52% 42
2019
Q3 		$848K Buy
10,562
+32
+0.3% +$2.56K 0.53% 42
2019
Q2 		$843K Buy
10,530
+1
+0% +$77 0.54% 44
2019
Q1 		$836K Buy
+10,529
New +$787K 0.55% 42

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sage Rhino Capital's MRK Position: Q1 2026 in Review

Sage Rhino Capital increased its Merck (MRK) stake by 0.14% in Q1 2026, buying an estimated $1.73K and bringing the position to 10,414 shares worth $1.25M. The position accounts for 0.23% of the portfolio, ranked #84.

Sage Rhino Capital first reported a position in MRK in Q1 2019 and has held it in 29 quarters since. The position peaked at $1.4M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Sage Rhino Capital held 10,414 shares of Merck worth $1.25M as of Q1 2026.
  • Sage Rhino Capital bought 15 Merck shares in Q1 2026, an estimated $1.73K.
  • Merck made up 0.23% of Sage Rhino Capital's portfolio in Q1 2026, its #84 holding.
  • Sage Rhino Capital first reported a position in Merck in Q1 2019 and has held it in 29 quarters since.
  • Sage Rhino Capital's Merck position peaked at $1.4M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Sage Rhino Capital's 13F filing for Q1 2026, filed 28 Apr 2026.